Form 4: Myriad Genetics Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Dale Muzzey, Chief Scientific Officer of Myriad Genetics, sold shares to cover tax obligations related to vesting restricted stock units.
Summary
- On April 14, 2025, Dale Muzzey, the Chief Scientific Officer of Myriad Genetics, sold 942 shares of common stock to cover tax obligations.
- The sale price was $8.08 per share.
- Following the transaction, Muzzey directly owns 170,599 shares of Myriad Genetics.
- The shares were withheld by the company to satisfy tax obligations related to the vesting of restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral event. An executive selling shares to cover taxes is a normal occurrence and doesn't necessarily reflect a positive or negative outlook on the company.
Industry Context
Form 4 filings are a routine part of the stock market, providing transparency into the transactions of company insiders. This particular filing indicates a sale of shares to cover tax obligations, which is a common practice.
Key Dates
| Date | Description |
|---|---|
| 04/14/2025 | Date of transaction: Dale Muzzey sold shares of Myriad Genetics stock. |
| 04/15/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Myriad Genetics, Insider Trading, Dale Muzzey, Stock Sale, Tax Obligations, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.